Search

everythinglearnresearchcommunity

for

Search:↓

Dermoscopy improves diagnosis and treatment monitoring for children's skin infections, inflammations, and hair disorders.

Zinc can be a helpful secondary treatment for certain skin conditions, but more research is needed to guide its use.

Cognitive-behavioral therapy is the best treatment for hair-pulling disorder, and combining it with other therapies could improve results.

The new delivery system improves treatment for hair loss by enhancing drug absorption and effectiveness.

Dermatoscopy and videodermatoscopy are useful and reliable for tracking treatment progress in various skin conditions.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

New drug delivery systems improve treatment effectiveness and patient experience.

Inhaling medicine may reduce side effects and improve treatment for a major lung cancer type.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

The paper suggests a way to diagnose male hair loss and check treatment results using a dermoscope at four specific scalp points.

Premature graying of hair is often linked with other health issues, but treatment with biotin, zinc, and calcium pantothenate is not very effective.

Scalp tools, tracking progress, targeting scalp inflammation, and avoiding certain hair treatments can improve female hair loss treatment.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Hormonal imbalances may play a role in frontal fibrosing alopecia, and antiandrogenic drugs combined with steroids are currently the most effective treatment.

A woman with acromegaly experienced severe hair loss from a drug called Lanreotide Autogel, which improved after stopping the treatment.

The 532 nm laser effectively reduces facial vascular and pigmented lesions, with the VISIA system reliably assessing treatment results.

A 66-year-old woman's thick scalp and hair loss were confirmed as lipedematous alopecia, a rare condition possibly influenced by genetics, with no effective treatment known.

New treatments and technologies in laser medicine show promise for improving skin conditions, fat reduction, cancer treatment, wound healing, and hair restoration.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.

Intralesional corticosteroids are best for mild alopecia areata, and DPCP is best for severe cases.

Topical tacalcitol ointment can help improve symptoms of EFFC.

Oral minoxidil effectively increases hair growth in male baldness but can cause side effects like excessive hair growth and swelling.

Oral minoxidil improved male baldness, but had side effects; certain antibiotics effectively treated a rare scalp condition; hair transplants might trigger another scalp condition.

Terbinafine and itraconazole are more effective against Microsporum canis than fluconazole and griseofulvin.

Pill organizers and cutters can help with taking medication regularly but may affect the medication's effectiveness and safety.

The COVID-19 quarantine in Turkey disrupted dermatological care, increased stress-related skin issues, and showed the need for psychological support and teledermatology.

Nanoparticles improve drug delivery through the skin but more research is needed on their long-term effects and skin penetration challenges.

Topical clobetasol is recommended over mycophenolate mofetil for treating Lichen Planopilaris due to better safety and patient satisfaction.

Combining CGF and microneedling with betamethasone effectively treats resistant alopecia areata.